Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy

Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 4

Abstract

Non-muscle invasive bladder cancer is a heterogeneous disease with widely varying risks of recurrence and progression to muscle invasion. Risk stratification within current treatment guidelines are an attempt to address this heterogeneity. This heterogeneity stems from a number of pathologic characteristics as well as recurrence status. Radical cystectomy, while the definitive, curative therapy for muscle invasive disease, is not often utilized for non-muscle invasive disease, even when it may be a superior option to bladder-sparing therapy. A majority of American Urologists have been reported to defer cystectomy for less invasive therapies when it is a guideline driven option. Both cystectomy and bladder-sparing therapy have excellent oncologic outcomes, but very different morbidity and mortality profiles. Timely, initial cystectomy provides improved oncologic outcomes for patients with high-risk non-muscle invasive bladder cancer, as opposed to delayed cystectomy following prolonged, failed bladder-sparing therapy. Patient selection is paramount when considering timely, initial cystectomy, given the increased rates of morbidity and mortality. The heterogeneity of non-muscle invasive pathologic characteristics includes a number of factors that may help differentiate patients who would benefit from a timely, initial cystectomy as opposed to bladder-sparing therapy. A rapidly evolving understanding of bladder cancer biology may help improve risk stratification and further aid in the selection of patients for timely, initial cystectomy.

Authors and Affiliations

George E. Koch, Sam S. Chang

Keywords

Related Articles

Effect of Multidisciplinary Approach in Diagnosis of Renal Sinus Fat Invasion in Renal Cell Cancer

Objective: In order to make the most appropriate treatment decision for kidney masses, accurate radiological evaluation is vital. In this study, we aimed to discuss how would be the concordance between a multidisciplinar...

Evaluating the Effects of Different Ischaemia Techniques on Functional Outcomes of Laparoscopic Partial Nephrectomy

Objective: This study aimed to investigate the influence of different ischaemia techniques on short-term and one year renal function following laparoscopic partial nephrectomy (LPN). Materials and Methods: Data of 359 p...

“Atypical Cell’’ Parameter in Automated Urine Analysis for the Diagnosis of Bladder Cancer: A Retrospective Pilot Study

Objective: To evaluate the application of an automated urine analyzer (AUA) for the diagnosis of bladder cancer (BC). Materials and Methods: A retrospective data analysis of 2365 urine specimens from the department of u...

Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes?

Homologous recombination (HR) is a major repair mechanism of DNA damage. Platin-based agents are known to be more effective in patients with impaired HR mechanism. Previous studies combined platin compounds with docetaxe...

Download PDF file
  • EP ID EP691633
  • DOI 10.4274/uob.galenos.2020.1549
  • Views 114
  • Downloads 0

How To Cite

George E. Koch, Sam S. Chang (2020). Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy. The Bulletin of Urooncology, 19(4), -. https://europub.co.uk/articles/-A-691633